“Unlike radiation therapy that's got toxicity to it as it enters the body and exits the body and leaves large areas of necrotic tissue, histotripsy is very different in that there's generally no damage going in or going out.” HistoSonics’ CEO Mike Blue explains about the Edison system. He then in depth with BI analyst Matt Henriksson on how the Edison histotripsy technology destroys targeted cancer cells, how it differentiates from other cancer treatment options, and how the company plans to expand the use of Edison from lung cancer to kidney, pancreas and prostate indications. Also tune in to learn how the recent acquisition announcement can accelerate its momentum to build out the clinical data and commercialization of Edison.

<p>&ldquo;Unlike radiation therapy that's got toxicity to it as it enters the body and exits the body and leaves large areas of necrotic tissue, histotripsy is very different in that there's generally no damage going in or going out.&rdquo; HistoSonics&rsquo; CEO Mike Blue explains about the Edison system. He then in depth with BI analyst Matt Henriksson on how the Edison histotripsy technology destroys targeted cancer cells, how it differentiates from other cancer treatment options, and how the company plans to expand the use of Edison from lung cancer to kidney, pancreas and prostate indications. Also tune in to learn how the recent acquisition announcement can accelerate its momentum to build out the clinical data and commercialization of Edison.</p>

Vanguards of Healthcare is a series of exclusive conversations with management teams and thought leaders discussing changes on the forefront of the industry, including innovations in medical products and technologies, advances in clinical research, new service models, wellness and regulations.

<p>Vanguards of Healthcare is a series of exclusive conversations with management teams and thought leaders discussing changes on the forefront of the industry, including innovations in medical products and technologies, advances in clinical research, new service models, wellness and regulations.</p>

Vanguards of Healthcare by Bloomberg Intelligence

HistoSonics Provides Ultrasound Options to Treat Tumors

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/31bb93b1-941b-434d-80e8-b338011a5e57/transcript